期刊文献+

The effect of monoamines reuptake inhibitors on aerobic exercise performance in bank voles from a selection experiment

原文传递
导出
摘要 Exercise performance depends on both physiological abilities (e.g., muscle strength) and behavioral characteristics (e.g., motivati on). We tested the hypothesis that evoluti on of in creased aerobic exercise performanee can be facilitated by evolution of neuropsychological mechanisms responsible for motivation to undertake physical activity. We used a unique model system: lines of bank voles Myodes glareolus selected for high swim-induced aerobic metabolism ("aerobic" A lines). In gen eration 21, voles from the 4 A lines achieved a 57% higher /y voluntary maximum" swiminduced aerobic metabolism (V02swim) than voles from 4 unselected,"control" C lines. In C lines, V02swim was 9% lower than the maximum forced-exercise aerobic metabolism (VO2run;P= 0.007), while in A lines it was even higher than VO2run, although not significantly (4%, P=0.15). Thus, we hypothesized that selection changed both the aerobic capacity and the neuronal mechanisms behi nd motivation to un dertake activity. We investigated the influe nee of reuptake in hibitors of dopamine (DARI), serotonin (SSRI), and norepinephrine (NERI) on VOaSwim. The drugs decreased V02swim both in C and A lines (% decrease compared with saline: DARI 8%, P< 0.001;SSRI 6%, P< 0.001;NERI 8%, P< 0.001), but the proportional response differed between selection directions only for NERI (stronger effect in C lines: P= 0.008) and the difference was marginally non-significant for SSRI (P= 0.07) and DARI (P= 0.06). Thus, the results suggest that all the 3 monoamines are involved in signaling pathways controlling the motivation to be active and that norepinephrine could have played a role in the evolution of increased aerobic exercise performance in our animal model.
出处 《Current Zoology》 SCIE CAS CSCD 2019年第4期409-419,共11页 动物学报(英文版)
分类号 Q [生物学]
  • 相关文献

参考文献1

二级参考文献42

  • 1Arena R, Myers J, Guazzi M, 2010. The future of aerobic exercise testing in clinical practice: is it the ultimate vital sign? Future Cardiol 6:325-342.
  • 2Biederman J, 2005. Attention-deficit/hyperactivity disorder: a selective over- view. Biol Psychiatry 57;1215-1220.
  • 3Booth FW, Lees JS, 2007. Fundamental questions about genes, inactivity, and chronic diseases. Physiol Genomics 28:146-157.
  • 4Cryan JF, Dalvi A, Jin S, Hirsch BR, Lucki I et al., 2001. Use of dopamine- hydroxylase- deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. J Pharmacol Exp Ther 298:651-657.
  • 5Dalla C, Antoniou K, Kokras N, Drossopoulou G, Papathanasiou Get al., 2008. Sex differences in the effects of two stress paradigms on dopaminergic on. Physiol Behav 93:595-605.
  • 6Davis JM, Bailey SP, 1997. Possible mechanisms of central nervous system fa- tigue during exercise. Med Sci Sports Exerc 29:45-57.
  • 7Dietrich A, McDaniel WF, 2004. Endocannabinoids and exercise. BrJ Sports Med 38:536-541.
  • 8Ekkekakis P, Hall EE, Petruzzello SJ, 2005. Variation and homogeneity in af fective responses to physical activity of varying intensities: an alternative perspective on dose - response based on evolutionary considerations. J Sports Sci 23:477-500.
  • 9Gainetdinov RR, Jones SR, Caron MC, 1999. Functional hyperdopaminergia in dopamine transporter knock-out mice. Biol Psychiatry 46:303-311.
  • 10Garland T, Carter PA, 1994. Evolutionary physiology. Annu Rev Physiol 56:579-621.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部